Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Drug-eluting Balloon Catheters Market to reach USD 1047.15 million by the end of 2029

Global Drug-eluting Balloon Catheters Market Size study & Forecast, by Drug (Paclitaxel, Sirolimus, Others) by Indication (Coronary Intervention, Peripheral Intervention), by End-user (Hospitals & ASCs, Specialty Clinics and Catheterization Laboratories) and Regional Analysis, 2022-2029

Product Code: HLSMDE-40374339
Publish Date: 25-01-2023
Page: 200

Global Drug-eluting Balloon Catheters Market is valued at approximately USD 529.4 million in 2021 and is anticipated to grow with a healthy growth rate of more than 8.9% over the forecast period 2022-2029. Drug-eluting balloon catheters also generally named drug-coated balloon catheters are semi-compliant angioplasty balloons used to deliver anti-proliferative drugs via inflated balloons. It helps in eluting the drug in the targeted vessel and lessens the negative impact of late thrombosis without implanting a permanent foreign object. The balloon technology is based on the theory of targeted medication delivery, which promotes quick artery wall repair and inhibits the growth of smooth muscle cells. The global market growth is likely to be driven by the factors such as increasing cases of peripheral and coronary artery diseases, the growing geriatric population leading to cardiovascular diseases, coupled with the rising need for surgical interventions.

Surging demand for minimally invasive procedures is acting as a catalyzing factor in the market growth across the globe. For instance, as per the NEWS Medical Life Sciences article released in December 2021, drug-coated balloon catheters are highly used with minimally invasive procedures and gaining high traction as replacements over dangerous stent treatment the myocardial infarction. Similarly, according to the NCBI article released in February 2021, the drug-coated balloon offers a wide range of benefits such as minimal side effects than drug-eluting stents, which creates it as a most adaptive therapeutics approach for coronary disease. Accordingly, the high preference towards minimally invasive procedures owing to its leads surgeries less painful and helps in fast recovery. Moreover, the rising introduction of paclitaxel-coated balloon catheter products, as well as the increasing technological advancements in drug-eluting balloon catheters are presenting various lucrative opportunities over the forecasting years.
However, the high cost of development and commercialization of drug-eluting balloons, along with the adverse effects and product recalls are challenging the market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Drug-eluting Balloon Catheters Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the market in terms of revenue, owing to the rising incidences of heart diseases and the availability of advanced healthcare facilities. Whereas, the Asia Pacific is also expected to grow with the highest CAGR during the forecast period. Factors such as the rising prevalence of peripheral artery disease, growing patient population, as well as increasing preference for minimally invasive procedures are propelling the demand for drug-eluting balloon catheters in the market space.

Major market players included in this report are:
Medtronic Plc
Koninklijke Philips N.V.
Boston Scientific Corporation
BD (Becton, Dickinson and Company)
B. Braun SE
Meril Life Sciences Pvt. Ltd.
Cordis Corporation
MicroPort Medical (Group) Co., Ltd.
Terumo Corporation

Recent Developments in the Market:
 In August 2022, BD unveiled the introduction of the first-in-human prevision trial to assess the safety and effectiveness of the peripheral sirolimus drug-coated balloon (DCB). The purpose of the trials was to evaluate sirolimus’ efficacy as a future therapy option for people with peripheral artery disease (PAD).
 In January 2021, MicroPort Medical (Group) Co., Ltd. announced that they received an EU CE mark for their Reewarm PTX Drug Coated Balloon PTA catheter for femoral popliteal artery indication during percutaneous transluminal angioplasty.
 In November 2020, Boston Scientific Corporation declared that the Ranger, a drug-eluting balloon catheter received approval from U.S. Food & Drug Administration (FDA). The product is specially designed to treat patients with PAD, Proximal Popliteal Artery (PPA),a dn Superficial Femoral Artery (SFA).

Global Drug-eluting Balloon Catheters Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Drug, Indication, End-user, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Drug:
By Indication:
Coronary Intervention
Peripheral Intervention
By End-user:
Hospitals & ASCs
Specialty Clinics and Catheterization Laboratories
By Region:
North America
Asia Pacific
South Korea
Latin America
Rest of the World

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Million)
1.2.1. Drug-eluting Balloon Catheters Market, by Region, 2019-2029 (USD Million)
1.2.2. Drug-eluting Balloon Catheters Market, by Drug, 2019-2029 (USD Million)
1.2.3. Drug-eluting Balloon Catheters Market, by Indication, 2019-2029 (USD Million)
1.2.4. Drug-eluting Balloon Catheters Market, by End-user, 2019-2029 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Drug-eluting Balloon Catheters Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Drug-eluting Balloon Catheters Market Dynamics
3.1. Drug-eluting Balloon Catheters Market Impact Analysis (2019-2029)
3.1.1. Market Drivers Increasing cases of peripheral and coronary artery diseases Surging demand for minimally invasive procedures
3.1.2. Market Challenges High cost of development and commercialization of drug-eluting balloons Adverse effects and product recalls
3.1.3. Market Opportunities Rising introduction of paclitaxel-coated balloon catheter products Increasing technological advancements in drug-eluting balloon catheters
Chapter 4. Global Drug-eluting Balloon Catheters Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Drug-eluting Balloon Catheters Market, by Drug
6.1. Market Snapshot
6.2. Global Drug-eluting Balloon Catheters Market by Drug, Performance – Potential Analysis
6.3. Global Drug-eluting Balloon Catheters Market Estimates & Forecasts by Drug 2019-2029 (USD Million)
6.4. Drug-eluting Balloon Catheters Market, Sub Segment Analysis
6.4.1. Paclitaxel
6.4.2. Sirolimus
6.4.3. Others
Chapter 7. Global Drug-eluting Balloon Catheters Market, by Indication
7.1. Market Snapshot
7.2. Global Drug-eluting Balloon Catheters Market by Indication, Performance – Potential Analysis
7.3. Global Drug-eluting Balloon Catheters Market Estimates & Forecasts by Indication 2019-2029 (USD Million)
7.4. Drug-eluting Balloon Catheters Market, Sub Segment Analysis
7.4.1. Coronary Intervention
7.4.2. Peripheral Intervention
Chapter 8. Global Drug-eluting Balloon Catheters Market, by End-user
8.1. Market Snapshot
8.2. Global Drug-eluting Balloon Catheters Market by End-user, Performance – Potential Analysis
8.3. Global Drug-eluting Balloon Catheters Market Estimates & Forecasts by End-user 2019-2029 (USD Million)
8.4. Drug-eluting Balloon Catheters Market, Sub Segment Analysis
8.4.1. Hospitals & ASCs
8.4.2. Specialty Clinics and Catheterization Laboratories
Chapter 9. Global Drug-eluting Balloon Catheters Market, Regional Analysis
9.1. Drug-eluting Balloon Catheters Market, Regional Market Snapshot
9.2. North America Drug-eluting Balloon Catheters Market
9.2.1. U.S. Drug-eluting Balloon Catheters Market Drug breakdown estimates & forecasts, 2019-2029 Indication breakdown estimates & forecasts, 2019-2029 End-user breakdown estimates & forecasts, 2019-2029
9.2.2. Canada Drug-eluting Balloon Catheters Market
9.3. Europe Drug-eluting Balloon Catheters Market Snapshot
9.3.1. U.K. Drug-eluting Balloon Catheters Market
9.3.2. Germany Drug-eluting Balloon Catheters Market
9.3.3. France Drug-eluting Balloon Catheters Market
9.3.4. Spain Drug-eluting Balloon Catheters Market
9.3.5. Italy Drug-eluting Balloon Catheters Market
9.3.6. Rest of Europe Drug-eluting Balloon Catheters Market
9.4. Asia-Pacific Drug-eluting Balloon Catheters Market Snapshot
9.4.1. China Drug-eluting Balloon Catheters Market
9.4.2. India Drug-eluting Balloon Catheters Market
9.4.3. Japan Drug-eluting Balloon Catheters Market
9.4.4. Australia Drug-eluting Balloon Catheters Market
9.4.5. South Korea Drug-eluting Balloon Catheters Market
9.4.6. Rest of Asia Pacific Drug-eluting Balloon Catheters Market
9.5. Latin America Drug-eluting Balloon Catheters Market Snapshot
9.5.1. Brazil Drug-eluting Balloon Catheters Market
9.5.2. Mexico Drug-eluting Balloon Catheters Market
9.5.3. Rest of Latin America Drug-eluting Balloon Catheters Market
9.6. Rest of The World Drug-eluting Balloon Catheters Market

Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Medtronic Plc Key Information Overview Financial (Subject to Data Availability) Product Summary Recent Developments
10.2.2. Koninklijke Philips N.V.
10.2.3. Boston Scientific Corporation
10.2.4. BD (Becton, Dickinson and Company)
10.2.5. B. Braun SE
10.2.6. Meril Life Sciences Pvt. Ltd.
10.2.8. Cordis Corporation
10.2.9. MicroPort Medical (Group) Co., Ltd.
10.2.10. Terumo Corporation
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com


Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.
Enquiry Now